![NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) protein complex. Plays a role in cancer and inflammation. Cartoon representatio Stock Photo - Alamy NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) protein complex. Plays a role in cancer and inflammation. Cartoon representatio Stock Photo - Alamy](https://c8.alamy.com/comp/J3PB5M/nf-kb-nuclear-factor-kappa-light-chain-enhancer-of-activated-b-cells-J3PB5M.jpg)
NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) protein complex. Plays a role in cancer and inflammation. Cartoon representatio Stock Photo - Alamy
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci](https://www.prosci-inc.com/wp-content/uploads/2021/12/SARS-CoV-2-COVID-19-full-length-Spike-S1-Kappa-India-Dec-2020-B-1-617-1-Variant-Recombinant-Protein_SDS_21-823.jpg)
SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci
![Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28324-6/MediaObjects/41467_2022_28324_Fig1_HTML.png)
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications
![SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci](https://www.prosci-inc.com/wp-content/uploads/2021/12/SARS-CoV-2-COVID-19-full-length-Spike-S1-Kappa-India-Dec-2020-B-1-617-1-Variant-Recombinant-Protein_picture_21-823.jpg)